Related Experiment Video
Updated: May 28, 2026
04:22
Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis
Published on: March 3, 2023
Current treatment for colorectal liver metastases
Evangelos P Misiakos1, Nikolaos P Karidis, Gregory Kouraklis
1Third Department of Surgery, Medical School, University of Athens, Attikon University Hospital, Athens 12462, Greece.
World Journal of Gastroenterology
|November 1, 2011
Summary
Surgical resection is the best option for colorectal liver metastases survival. Innovations and neoadjuvant chemotherapy increase resectability, improving outcomes for more patients with liver cancer.
Area of Science:
- Oncology
- Surgical Oncology
- Hepatobiliary Surgery
Background:
- Colorectal cancer liver metastases significantly impact patient survival.
- Surgical resection offers the best survival rates, but many tumors are unresectable at diagnosis.
Purpose of the Study:
- To review current strategies for increasing surgical resectability of colorectal liver metastases.
- To discuss advancements in surgical techniques and neoadjuvant therapies.
- To emphasize the importance of a multidisciplinary approach in managing these cases.
Main Methods:
- Review of surgical innovations like staged resection and portal vein embolization.
- Analysis of neoadjuvant chemotherapy's role in downstaging unresectable tumors.
- Evaluation of ablative techniques as adjuncts or alternatives to resection.
Main Results:
- Surgical resection can achieve up to 58% five-year survival in selected patients.
- Surgical innovations have increased resection rates, particularly for bilobar disease.
- Neoadjuvant chemotherapy enables resection in up to 38% of previously unresectable cases.
Conclusions:
- Increasing resectability and refining surgical indications are key research goals.
- Surgical innovations and neoadjuvant chemotherapy expand treatment options.
- Individualized, multidisciplinary management is crucial for optimal patient outcomes.
